Missense mutations in the beta-myosin heavy-chain gene cause central core disease in hypertrophic cardiomyopathy.

Lameh Fananapazir(National Heart Lung and Blood Institute), Nava Epstein(Sheba Medical Center), F Cyran(National Heart Lung and Blood Institute), Gabriel Cohn(National Heart Lung and Blood Institute), Marinos C. Dalakas(Thomas Jefferson University)
Proceedings of the National Academy of Sciences
May 1, 1993
10.1073/pnas.90.9.3993
Cited by 201

Related Papers

Targeted integration of adeno‐associated virus (AAV) into human chromosome 19.
|The EMBO Journal|1991|774
Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy.
|Circulation|1994|383
Complement in neurological disorders and emerging complement-targeted therapeutics
|Nature Reviews Neurology|2020|354
Skeletal muscle expression and abnormal function of beta-myosin in hypertrophic cardiomyopathy.
|Journal of Clinical Investigation|1993|242
Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the beta-myosin heavy chain gene. A 908Leu----Val mutation and a 403Arg----Gln mutation.
|Circulation|1992|230